Prognostic Factors in Patients Receiving An Allogeneic Stem Cell Transplantation for Relapsed AML. Results of the Prospective AML 295 and 01/99 Studies

被引：0
|
作者：
Krauter, Juergen [1 ]
Heil, Gerhard [2 ]
Hoelzer, Dieter [3 ]
Martin, Hans [3 ]
Ottmann, Oliver G. [3 ]
Finke, Juergen [4 ]
Luebbert, Michael [5 ]
Heit, Wolfgang [6 ]
Fiedler, Walter [7 ]
Kanz, Lothar [8 ]
Schlimok, Guenter [9 ]
Kirchner, Hartmut [10 ]
Raghavachar, Aruna [11 ]
Brugger, Wolfram [12 ]
Doehner, Hartmut [13 ]
Ganser, Arnold [1 ]
机构：
[1] Hannover Med Sch, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, D-3000 Hannover, Germany
[2] Krankenhaus Ludenscheid, Ludenscheid, Germany
[3] JW Goethe Univ Hosp, Frankfurt, Germany
[4] Univ Med Ctr Freiburg, Freiburg, Germany
[5] Univ Freiburg, Med Ctr, D-7800 Freiburg, Germany
[6] Kliniken Essen Sud, Essen, Germany
[7] Univ Hosp Eppendorf, Dept Hematol & Oncol, Hamburg, Germany
[8] Univ Tubingen, Tubingen, Germany
[9] Klinikum Augsburg, Med Klin 2, Augsburg, Germany
[10] Klinik Hannover, Hannover, Germany
[11] HELIOS Klinikum Wuppertal, Med Klin 1, Wuppertal, Germany
[12] Hosp Villingen Schwenningen, Schwenningen, Germany
[13] Univ Ulm, Ulm, Germany
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [21] GO-FLAG Regimen as a Bridge Therapy to Allogeneic Stem Cell Transplantation in Refractory/relapsed AML Patients
    Ayubova, Bella
    Bondarenko, Sergey
    Moiseev, Ivan
    Uspenskaya, Olga
    Karyagina, Elena
    Misyurina, Elena
    Zhelnova, Evgenia
    Alyanskiy, Alexander
    Babenko, Elena
    Barkhatov, Ildar
    Gindina, Tatyana
    Kulagin, Alexander
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 197 - 197
  • [22] Monosomal Karyotype Provides Better Prognostic Prediction After Allogeneic Stem Cell Transplantation in AML Patients
    Oran, Betul
    Dolan, Michelle
    Ma, Linan
    Brunstein, Claudio
    Warlick, Erica
    Weisdorf, Daniel J.
    BLOOD, 2009, 114 (22) : 218 - 219
  • [23] Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation
    Park, Woochan
    Byun, Ja Min
    Hong, Junshik
    Kim, Inho
    Shin, Dong-Yeop
    Park, Seonyang
    Koh, Youngil
    Yoon, Sung-Soo
    ANNALS OF HEMATOLOGY, 2023, 102 (03) : 629 - 639
  • [24] Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation
    Woochan Park
    Ja Min Byun
    Junshik Hong
    Inho Kim
    Dong-Yeop Shin
    Seonyang Park
    Youngil Koh
    Sung-Soo Yoon
    Annals of Hematology, 2023, 102 : 629 - 639
  • [25] Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
    Schmid, Christoph
    Labopin, Myriam
    Nagler, Arnon
    Niederwieser, Dietger
    Castagna, Luca
    Tabrizi, Reza
    Stadler, Michael
    Kuball, Juergen
    Cornelissen, Jan
    Vorlicek, Jiri
    Socie, Gerard
    Falda, Michele
    Vindelov, Lars
    Ljungman, Per
    Jackson, Graham
    Kroeger, Nicolaus
    Rank, Andreas
    Polge, Emmanuelle
    Rocha, Vanderson
    Mohty, Mohamad
    BLOOD, 2012, 119 (06) : 1599 - 1606
  • [26] ELN 2017 Risk Classification Predicts Survival of AML Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
    Hansen, Doris K.
    Nieder, Michael L.
    Thompson, Zachary
    Kim, Jongphil
    Pidala, Joseph A.
    Nishihori, Taiga
    Khimani, Farhad
    Davila, Marco L.
    Mishra, Asmita
    Lazaryan, Aleksandr
    Sallman, David
    Elmariah, Hany
    Sweet, Kendra
    Liu, Hien
    Perez, Lia Elena
    Komrokji, Rami
    Fernandez, Hugo
    Lancet, Jeffrey E.
    Anasetti, Claudio
    Bejanyan, Nelli
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [27] Prognostic factors in autologous stem cell transplantation (ASCT) for patients with MDS and AML following MDS
    de Witte, T
    van Biezen, A
    Hermans, J
    Laporte, JP
    Meloni, G
    Tura, S
    Holowiecki, J
    Boogaerts, M
    Marcus, R
    Mauri, SB
    Cahn, JY
    Diez-Martin, JL
    Niederwieser, D
    Gratwohl, A
    Apperley, J
    BONE MARROW TRANSPLANTATION, 1999, 23 : S154 - S154
  • [28] Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation
    Grimm, Juliane
    Jentzsch, Madlen
    Bill, Marius
    Goldmann, Karoline
    Schulz, Julia
    Niederwieser, Dietger
    Platzbecker, Uwe
    Schwind, Sebastian
    BLOOD ADVANCES, 2020, 4 (16) : 3864 - 3874
  • [29] The outcomes of allogeneic stem cell transplantation in AML patients with monosomal karyotypes.
    Sohn, Sang Kyun
    Lee, Soo Jung
    Kim, Jong Gwang
    Chae, Yee Soo
    Kang, Byung Woog
    Moon, Joon Ho
    Baek, Jin Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma
    H Shimizu
    T Saitoh
    M Tanaka
    T Mori
    T Sakura
    N Kawai
    Y Kanda
    C Nakaseko
    S Yano
    H Fujita
    S Fujisawa
    S Miyawaki
    H Kanamori
    S Okamoto
    Leukemia, 2012, 26 : 2469 - 2473
12345